Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W P Burkard

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Receptor Research|January 1, 1984
Characteristics of 3H-tifluadom binding in guinea-pig brain membranesW P Burkard, P M Müller, N Flück
European Journal of Pharmacology|February 26, 1985
The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in miceW P Burkard, E P Bonetti, W Haefely
Biochemical Pharmacology|January 1, 1971
Cyclic adenosine 3',5'-monophosphate and enylcyclase in liver, adipose tissue and brain of rats treated with beta-pyridylcarbinolW P Burkard, H Lengsfeld, K F Gey
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in ratsR Kettler, M Da Prada, W P Burkard
Advances in Biochemical Psychopharmacology|January 1, 1980
Tricyclic antidepressantsH H Keller, W P Burkard, M Da Prada
The Journal of Pharmacy and Pharmacology|August 1, 1971
1,3-Bis(4-(p-methoxyphenyl)piperazinyl)-2-propanol (Ro 8-2580): a new monoamine depletorW P Burkard, M Jalfre, J E Blum, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1972
Blockade of central 5-hydroxytryptamine receptors by methiothepinM A Monachon, W P Burkard, M Jalfre, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Short-lasting and reversible inhibition of monoamine oxidase-A by moclobemideM Da Prada, R Kettler, H H Keller, et al.
Journal of Medicinal Chemistry|February 1, 1989
Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonistH Schmidhammer, W P Burkard, L Eggstein-Aeppli, et al.
Journal of Neurochemistry|September 1, 1981
Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levelsH Möhler, W P Burkard, H H Keller, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Receptor Research|January 1, 1984
Characteristics of 3H-tifluadom binding in guinea-pig brain membranesW P Burkard, P M Müller, N Flück
European Journal of Pharmacology|February 26, 1985
The benzodiazepine antagonist Ro 15-1788 reverses the effect of methyl-beta-carboline-3-carboxylate but not of harmaline on cerebellar cGMP and motor performance in miceW P Burkard, E P Bonetti, W Haefely
Biochemical Pharmacology|January 1, 1971
Cyclic adenosine 3',5'-monophosphate and enylcyclase in liver, adipose tissue and brain of rats treated with beta-pyridylcarbinolW P Burkard, H Lengsfeld, K F Gey
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Comparison of monoamine oxidase-A inhibition by moclobemide in vitro and ex vivo in ratsR Kettler, M Da Prada, W P Burkard
Advances in Biochemical Psychopharmacology|January 1, 1980
Tricyclic antidepressantsH H Keller, W P Burkard, M Da Prada
The Journal of Pharmacy and Pharmacology|August 1, 1971
1,3-Bis(4-(p-methoxyphenyl)piperazinyl)-2-propanol (Ro 8-2580): a new monoamine depletorW P Burkard, M Jalfre, J E Blum, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 1, 1972
Blockade of central 5-hydroxytryptamine receptors by methiothepinM A Monachon, W P Burkard, M Jalfre, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Short-lasting and reversible inhibition of monoamine oxidase-A by moclobemideM Da Prada, R Kettler, H H Keller, et al.
Journal of Medicinal Chemistry|February 1, 1989
Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonistH Schmidhammer, W P Burkard, L Eggstein-Aeppli, et al.
Journal of Neurochemistry|September 1, 1981
Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levelsH Möhler, W P Burkard, H H Keller, et al.
Pageof 4